Schedule 13G ownership disclosure
X4 PHARMACEUTICALS INC
Security class unavailable · CUSIP: 98420X103
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,205,816
- Percent of class
- 4.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-001745
- Form type
- SC 13G
- Filer
- ACORN BIOVENTURES, L.P.
- CIK
- CIK 1766853
- Filed
- Feb 14, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership